• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Teladoc Health, Dexcom Offers CGM-Powered Insights to People with Type 2 Diabetes

Share:

January 15, 2021

Highlights on this story:
  • Teladoc Health and Dexcom announced an expanded partnership on a new offering measures the impact of continuous glucose monitoring and real-time health recommendations for people with Type 2 diabetes at no cost.

Teladoc Health, Inc., the first and only comprehensive virtual care system, and DexCom, Inc., the leader in real-time continuous glucose monitoring (CGM), today announced that joint Livongo for Diabetes and Dexcom members will now receive CGM-powered insights. In January of 2020, Livongo, which merged with Teladoc Health in October, and Dexcom announced the first phase of their strategic relationship, a data-sharing agreement for Livongo for Diabetes members using Dexcom CGM technology.

Expanded Partnership Details

“We are excited to announce the next phase of our relationship with Teladoc Health, along with launching a commercial pilot demonstrating how Dexcom’s leading CGM combined with Teladoc Health’s data science capabilities enhance the diabetes management experience,” said Matt Dolan, senior vice president and general manager of new markets for Dexcom. “We have received powerful feedback from people with Type 2 diabetes using our technology, and through additional innovative product features, we fully anticipate that we will deliver an even greater impact.”

The expanded partnership includes two developments:

1. Enhanced product capabilities through CGM-powered insights, a new set of features and reports that help members more easily visualize their health information and understand how lifestyle decisions affect their blood glucose levels. By combining Dexcom CGM data with additional signals from Teladoc Health, including activity data and food intake, CGM-powered insights offer members a complete health profile and recommendations that support ongoing diabetes management.

2. A pilot program demonstrating the impact of CGM-powered insights for people with Type 2 diabetes. Eligible members will receive an integrated product experience including the Livongo for Diabetes program, Dexcom CGM technology and CGM-powered insights at no cost.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Teladoc Health’s partnership with Dexcom further empowers whole person health through an innovative combination of advanced technology and human expertise,” said Amar Kendale, chief product officer of Teladoc Health. “Our focus is to offer a consumer experience that makes it easy, safe and affordable for people to manage their health with confidence. We are excited about our continued work with Dexcom and new features that enable smarter care, leading to measurable consumer behavior change and better health outcomes.”

Why It Matters

It is estimated that 463 million adults around the world live with diabetes[1], a number expected to rise to 700 million by 2045. According to the Centers for Disease Control and Prevention, regular physical activity, weight management, and improved blood pressure management are important factors for preventing diabetes-related complications[2].

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Korean Government, Private Hospital Researchers Develop Medical Imaging Technology Using Machine LearningKorean Government, Private Hospital Researchers Develop Medical Imaging Technology Using Machine Learning
  • 23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics
  • Iterative Scopes Announces the Acquisition of Clinical Research Strategy Group and Precision ResearchIterative Scopes Announces the Acquisition of Clinical Research Strategy Group and Precision Research
  • Let’s Break A Deal: Bad Technology A Real Liability In Healthcare M&ALet’s Break A Deal: Bad Technology A Real Liability In Healthcare M&A
  • Google Health Studies App Launches in Partnership with Harvard Medical School & Boston Children’s HospitalGoogle Health Studies App Launches in Partnership with Harvard Medical School & Boston Children’s Hospital
  • GraphPad Acquires Biomatters to Form Industry Leading Life Sciences Software PlatformGraphPad Acquires Biomatters to Form Industry Leading Life Sciences Software Platform
  • Man-Made Intelligence In Healthcare Is Exciting, However, It Is No Reason To Overpay For ItMan-Made Intelligence In Healthcare Is Exciting, However, It Is No Reason To Overpay For It
  • Artificial Intelligence (AI) in Drug Discovery Market Size, Share, Growth: A Well-Defined Technological Growth Map with An Covid-19 Impact-AnalysisArtificial Intelligence (AI) in Drug Discovery Market Size, Share, Growth: A Well-Defined Technological Growth Map with An Covid-19 Impact-Analysis

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications